Introduction
Asthma is a common chronic inflammatory disease characterized by bronchial hyper-responsiveness, intermittent airflow obstruction and airway remodeling [1] . The prevalence of asthma is increasing worldwide, especially in children and young adults [2] . Asthma is one of the leading chronic childhood diseases affecting approximately 6.3 million of children under the age of 18 years in the United States, which not only leads to the huge economic burden, but also reduces life quality of patients [3] . The pathogenesis of asthma is complicated and is related to heredity, immunity, infection and environmental factors [4] .
ORMDL3 is a member of ORDML gene family (ORMDL-1, ORMDL-2, and ORMDL3), a family of endoplasmic reticulum proteins encoding transmembrane proteins [5] . ORMDL3 is widely distributed in the body organization and high expression in lung where it is predominantly localized to airway epithelial cells. ORMDL3 is related to severe asthma, childhood onset of asthma, rhinoviral wheezing illness and chemokines release, such as IL-6, IL-1β, and TNF-α [6] [7] [8] . In mouse lungs, increased ORMDL3 expression can be tested after exposed to a variety of stimuli, such as allergens, tobacco smoke and lipopolysaccharides [9] . Transfection of ORMDL3 into A549 cells induces expression of genes with potential importance to the pathogenesis of asthma including metalloproteases (metalloproteinase domain containing protein 8 [ADAM8], MMP-9), CC chemokines and CXC chemokines (IL-8 and CXCL-10) [10] . ORMDL3 plays an important role in regulating airway remodeling (smooth muscle, fibrosis, mucus) potentially via activating ATF6 UPR pathway, and/or through ATF6 independent genes (ADAM8, MMP-9) detected in airway epithelium of transgenic mice [11] .
The regulatory mechanism of ORMDL3 expression is important for investigating the etiology of childhood asthma. However, little is known about it. Epigenetic profiles in airway epithelium can be altered by some asthma-promoting environmental exposures, which demonstrated environmental epigenetic regulation may be an important mechanism in the etiology of asthma [12] . DNA methylation, included in the environmental epigenetic regulation, is an important way to regulate gene expression. Previous studies indicated that DNA methylation can contribute to the pathogenesis of asthma via well-known pathways, T such as T-cell differentiation and cytokine production [13, 14] . Nathalie Acevedo et al. reported that significant differences exist in 3 CpG sites between asthmatics and non-asthmatics and two of them in the CpG island of ORMDL3 (cg02305874 and cg16638648) [15] . In our study, we found ORMDL3 expression is higher in childhood asthma patients compared with controls. ORMDL3 overexpression significantly induced IL-6 and IL-8 release via p-ERK/MMP-9 signaling pathway in NHBE and BEAS-2B cells. Then, we paid our attention to the DNA methylation regulation mechanism for ORMDL3 expression. 5-Aza-CdR, as a global demethylating reagent, increased ORMDL3 expression in both mRNA and protein levels. Furthermore, 5-Aza-CdR decreased the percentage of DNA methylation of the CpG island in the ORMDL3 promoter and increased ORMDL3 promoter activity. In addition, 5-Aza-CdR induced IL-6 and IL-8 release through ORMDL3-mediated activation of p-ERK/ MMP-9 pathway. Hence, DNA methylation contributes to IL-6 and IL-8 release and ORMDL3 plays an essential role in it.
Materials and methods

Subjects
From 2015 to 2016, a total of 66 children childhood asthma cases and unrelated healthy controls from the Children's Hospital of Nanjing Medical University were included in our study. The diagnosis of asthma was based on the physician's diagnosis according to the American Thoracic Society (ATS, 2004) guidelines. Non-asthmatic children matched to cases by age, gender, ethnicity and geographic region were selected from the general pediatric clinic of the same hospital. The characteristics of patients and controls are listed in Fig. 1A and lung function test data show that in general asthma was well controlled in the asthmatic group. The peripheral blood mononuclear cells (PBMCs) were obtained from the cases and controls above with appropriate informed consent in the Nanjing Children's Hospital. All the study populations underwent comprehensive medical evaluation to make sure the accuracy of diagnosis. This study was approved by the Institutional Research Ethics Committee of Nanjing Children's Hospital and all participants provided written informed consent. We declared the research was carried out according to the World Medical Association Declaration of Helsinki.
Cell culture and chemicals
BEAS-2B cells were obtained from the American Type Culture Collection (ATCC, USA) and cultured in Dulbecco's modified Eagle's medium/F12 (Gibco, USA) with 10% fetal bovine serum (Gibco, USA) supplemented with 1% penicillin and streptomycin (Invitrogen, USA) at 5% CO 2 and 37°C incubator. Normal human bronchial epithelial cells were cultured in BEGM™ Bronchial Epithelial Cell Growth Medium (Lonza, Switzerland) according to the manufacturer's protocol. 5-aza-2′-deoxycytidine (5-Aza-CdR) was purchased from Sigma-Aldrich and CpG Methyltransferase (M.SssI) was purchased from Thermo Fisher Scientific.
Cell counting kit-8 (CCK-8) proliferation assay
Cell viability was detected using CCK-8 proliferation assay (Dojindo, Japan). Cells were seeded at a density of 3 × 10 3 cells/well in 96-well plates with 3 replicates. Cells were incubated at standard conditions for 1 h after 10 μl CCK-8 reagent was added and then the absorbance at 450 nm was measured with a microplate reader (Bio-Rad Laboratories, USA).
Enzyme-linked immunosorbent assay (ELISA)
NHBE and BEAS-2B cells were seeded into each well of 24-well plates and the supernatant was collected at 48 h after 5-Aza-CdR treatment. Fasting blood was collected in serum separator tubes (BD Biosciences, USA). After clot formation, centrifuge samples at 1000×g for 10 min and collect serum (Chinese children, n = 23, 12 asthma patients, 11 controls). IL-6 and IL-8 concentrations were measured by enzyme-linked immunosorbent assays (ELISA) according to the manufacturers' instructions (BD Biosciences, USA). The concentrations were calculated using a standard curve obtained with the recombinant kit standards. The data were analyzed using the Microplate Manager 6 software (Bio-Rad, USA).
Plasmids and transfection
Transcriptional start site (TSS) of human ORMDL3 promoter was set as + 1 according to Jin R reported [16] and the ORMDL3 genomic DNA fragment − 261 to + 133 was amplified by Quantitative real-time PCR (qRT-PCR) and digested with KpnI and BglII and then inserted into promoter-less luciferase expression plasmid pGL3-Basic (Promega, USA). The resulting plasmid was designated as pGL-261/+133. Lentivirus packaging cells were transfected with MCS-CBh-gcGFP-IRESpuromycin vector (GENECHEM, China) containing either the ORMDL3 knockdown (sh-ORMDL3) or ORMDL3 overexpression (ORMDL3) and a negative control sequence (NC), respectively. Lentiviral transduction was performed in NHBE and BEAS-2B cell lines. Pools of stable transductants were generated by selection using puromycin (4 μg/ml) for 2 weeks.
Transient transfections and luciferase reporter assays
According to the manufacturer's protocol, transient transfection of NHBE cells was conducted using Lipofectamine™ 3000 (Invitrogen, USA). The cells were seeded into 96-well plates (1.5 × 10 4 /well) 24 h prior to transfection. Then, 100 ng luciferase reporter plasmids and 4 ng pRL-TK plasmid were transfected into cells using Lipofectamine™ 3000. After treated with 5-Aza-CdR and M.SssI with 48 h, Luciferase assay was conducted by a Dual-luciferase Reporter Assay System (Promega, USA). Luciferase activity was normalized to the activity of pRL-TK. All results from at least three independent experiments.
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from cultured cells and blood samples using TRIzol reagent (Invitrogen, USA) and cDNA was synthesized using Primescript RT Reagent (Takara, China). The qRT-PCR was performed by using StepOne Plus Real-time PCR system (Applied Biosystems, USA) with SYBR® Premix Ex Taq™ Reagent (Takara, China).
The primers were used for qRT-PCR as follows:
forward, 5'-AACACGCGGGTGATGAACAG-3', reverse, 5'-AGGGACA CTCACAAACGGGA-3' for human ORMDL3 gene; forward, 5'-GGAGCGAGATCCCTCCAAAAT-3', reverse, 5'-GGCTGTTGTCATACTTCTCATGG-3' for human GAPDH gene.
Data analysis was performed with ABI Step One Software version 2.1 and the relative mRNA level was calculated using 2 -ΔΔCt method.
Western blot (WB)
Protein of BEAS-2B cells, NHBE cells and PBMCs were extracted using a Total Protein Extraction Kit (Keygentec, China) and protein concentrations were measured using the BCA Protein Assay kit (Pierce, USA). Protein were run on SDS-PAGE gels, blotted on nitrocellulose membrane, and immunodetected with primary antibodies against ORMDL3 (ab107639, 1:1000, Abcam), MMP-9 (ab38898, 1:1000, Abcam), p-ERK (#4370, 1:2000, CST) and ERK (#4695, 1:1000, CST). GAPDH (#5174, 1:1000, CST) and β-actin (#4970, 1:1000, CST) were detected as controls. Signals were visualized by ECL blotting detection reagents (Thermo Fisher Scientific, USA) and exposed to X-ray films which were scanned and quantitatively analyzed using Image Lab Software (Bio-Rad, USA).
Bisulfite-sequencing PCR (BSP)
Genomic DNA was extracted from NHBE cells, BEAS-2B cells and PBMCs, using a genomic DNA isolation kit (Biovision, USA). The bisulfite conversion method was used to modify the isolated genomic DNA using EpiTect Fast DNA Bisulfite Kit (Qiagen, Germany). Forward: 5'-GGGTATAGAAGTAAAAGTTGGAATTG-3' and Reverse: 5'-AACCCTA AAACCTCTTAATTCCTTC-3', as a primer for the predicted promoter region after bisulfite conversion, were designed by the SnapGene® Viewer 3.3.3. PCR was performed according to the following conditions: 95°C for 4 min, 40 cycles at 94°C for 30 s, 50°C for 30 s, and 72°C for 40 s. Analysis of PCR results were performed via an ABI 7900HT Real-Time PCR System 7900 (ABI, USA). Purified products were cloned into the pTG19-T vector (Generay, China) and then 10 individual clones were sequenced.
Statistical analysis
Statistical analyses were performed with SPSS 22.0 (Armonk, USA) and All data were presented as mean ± SD from three independent experiments. One-way analysis of variance and Student's t-test were used to analyze the differences between groups. Pearson correlation analysis was used to analyze the correlation between various factors. P < 0.05 was considered statistically significant.
Results
3.1. ORMDL3 is highly expressed in PBMC specimens of childhood asthma patients compared with controls ORMDL3 transcript level and protein level were investigated by qRT-PCR and WB. As shown in Fig. 1B-D , ORMDL3 mRNA level was higher in childhood asthma patients compared with PBMC specimens from normal subjects. WB analysis was consistent with qRT-PCR results.
ORMDL3 promotes production of IL-6 and IL-8 in vitro
Previous studies indicated transfection of ORMDL3 into A549 cells induces expression of genes with potential importance to the pathogenesis of asthma including metalloproteases (MMP-9 and ADAM-8), CC chemokines and CXC chemokines (IL-8 and CXCL-10) [10] . ORMDL3 may contribute to airway remodeling via regulating downstream pathways including metalloproteases, remodeling genes, and chemokines [8] . Therefore, we transfected NHBE and BEAS-2B cells with MCS-CBh-gcGFP-IRES-puromycin vector containing ORMDL3 overexpression (ORMDL3) and a negative control sequence (NC) respectively ( Fig. 2A-B) . We examined the production of IL-6 and IL-8 in the supernatant of NHBE and BEAS-2B cells. Samples were divided into ORMDL3 overexpression groups and negative control groups. We found that ORMDL3 overexpression led to a significant IL-6 and IL-8 increase in both NHBE and BEAS-2B cells (Fig. 2C-D) . Aberrant ERK activation has been observed in chronic inflammatory diseases [17] . For example, elevated ERK activity was observed in airway and alveolar epithelial cells of emphysema patients [18] . In ovalbumin-induced airway inflammation model, ERK inhibitor UO126 reduce cytokine production [19] . MMPs are proteolytic enzymes produced by epithelial and inflammatory cells and can induces infiltration of inflammatory cells through the basement membrane and extracellular matrix (ECM) by accelerating collagen and ECM deposition, which contribute to the progression of airway remodeling [20] . Previous studies indicated ORMDL3 may contribute to airway remodeling via the p-ERK/MMP-9 pathway [21] . To further study the mechanism of the production of IL-6 and IL-8 induced by ORMDL3 overexpression, we investigated the effects of ORMDL3 overexpression on p-ERK/MMP-9 pathway. WB showed that ORMDL3 overexpression elevated the expression of p-ERK/MMP-9 pathway in both NHBE and BEAS-2B cells (Fig. 2E-F) . The results suggested that overexpression ORMDL3 induced production of IL-6 and IL-8 and which might be mediated by the activation of p-ERK/ MMP-9 pathway.
5-Aza-CdR increases the mRNA and protein level of ORMDL3 in vitro
Environmental epigenetic regulation has been increasingly recognized as an important studied area to explore the complex pathogenesis of childhood asthma [22] . DNA methylation is one of the most well characterized epigenetic phenomena, which typically ensues at CpG islands in the promoter region of genes inhibiting gene expression [23] . 5-Aza-CdR is a DNMT inhibitor, which can be used to reduce DNMT gene expression and promote the transcription of genes. Firstly, we treated NHBE and BEAS-2B cells with different concentrations of 5-Aza-CdR for 48 h and then assessed cell viability using CCK-8 proliferation assay. Indeed, 5-Aza-CdR had no effect on cell survival up to 1 μmol/L in NHBE and BEAS-2B cells (Fig. 3A-B) , which was chosen for subsequent studies. Total RNA was isolated and qRT-PCR was conducted to detect ORMDL3 mRNA level after 5-Aza-CdR treatment. ORMDL3 mRNA expression increased by 8.3-fold in NHBE cells (Fig. 3C) . In BEAS-2B cells, there is an approximately 7.8-fold increase in the ORMDL3 mRNA expression after treated with 5-Aza-CdR. (Fig. 3E) . The results indicated ORMDL3 mRNA expression was upregulated in the treatment of 5-Aza-CdR in NHBE and BEAS-2B cells compared with controls. To explore the effects of 5-Aza-CdR on ORMDL3 expression at the protein level, total protein was extracted from NHBE and BEAS-2B cells and WB was carried out. As shown in Fig. 3D -F, ORMDL3 protein expression increased in 5-Aza-CdR-treated groups compared with controls in NHBE and BEAS-2B cells. 
5-Aza-CdR reduces the percentage of methylation of ORMDL3 promoter CpG island
Since de-methylating agent 5-Aza-CdR increased ORMDL3 expression, we hypothesized 5-Aza-CdR had an effect on the methylation status of the ORMDL3 promoter. Firstly, we used MethPrimer (http:// www.urogene.org/methprimer2/) to predict the CpG island in the ORMDL3 promoter region. The results indicated that ORMDL3 promoter contains only one CpG island with a length of 333 bp. Due to the fact that the CpG island contains transcription start sites, it may play an important role in regulating ORMDL3 transcriptional activity (Fig. 4A-B) . Genomic DNA was extracted from NHBE and BEAS-2B cells using genomic DNA isolation kit (Biovision, USA). All samples were divided into control and 5-Aza-CdR-treated group and were detected by BSP. As shown in Fig. 4C -F, 40 CpG sites were detected, percentage of methylation of ORMDL3 CpG island was decreased in the 5-Aza-CdR-treated group compared to controls in NHBE and BEAS-2B cells.
Methylation status of ORMDL3 promoter CpG island regulates its promoter activity
Methylation status of CpG island in the promoter region always regulated gene expression via influencing its promoter activity. we speculated ORMDL3 promoter activity may also be regulated by 5-AzaCdR. We inserted ORMDL3 genomic DNA fragment chr17:39927468-39927861 contained the CpG island in the ORMDL3 promoter region into the pGL3-Basic vector (Fig. 5A) and then transfected the plasmid into NHBE and BEAS-2B cells. As shown in Fig. 5C , 5-Aza-CdR induced a marked increase in promoter activity in NHBE and BEAS-2B cells compared with controls. Moreover, M.SssI, as the hypermethylation reagent, was used to investigate the effect of hypermethylation on the ORMDL3 promoter activity. The results indicated DNA hypermethylation significantly decreased the ORMDL3 promoter activity (Fig. 5D ).
5-Aza-CdR induces IL-6 and IL-8 release via increasing ORMDL3 expression
From the results above, we know that ORMDL3 promotes production of IL-6 and IL-8 via p-ERK/MMP-9 signaling pathway in NHBE and BEAS-2B cells and 5-Aza-CdR could increase ORMDL3 expression via influencing its CpG island in the promoter region. Hence, we were interested in the association between the treatment of NHBE cells with 5-Aza-CdR and the production of IL-6 and IL-8. We hypothesized that 5-Aza-CdR induced IL-6 and IL-8 release via increasing ORMDL3 expression. Firstly, we transfected NHBE cells with MCS-CBhgcGFP-IRES-puromycin vector containing ORMDL3 knockdown and a negative control sequence (NC) respectively (Fig. 6A-C) . After treatment of NHBE cells with 5-Aza-CdR for 48 h, IL-6 and IL-8 concentrations were measured by ELISA according to the manufacturers' instructions. As shown in Fig. 6D -E, 5-Aza-CdR significantly increased IL-6 and IL-8 release in NHBE cells while there was no obvious alteration after knocking down ORMDL3. To investigate the mechanisms underlying the phenomenon that 5-Aza-CdR induced IL-6 and IL-8 release, we detected the expression of p-ERK/MMP-9 pathway. In NHBE cells, 5-Aza-CdR significantly increased the expression of p-ERK/MMP-9 pathway. However, after knocking down ORMDL3, there is no difference in the expression of p-ERK/MMP-9 pathway between 5-Aza-CdRtreated groups and controls (Fig. 6F-G) . These data together support the idea that 5-Aza-CdR induced IL-6 and IL-8 release via increasing ORMDL3 expression.
Methylation status of ORMDL3 is associated with the production of IL-6 and IL-8 and the expression of p-ERK/MMP-9 pathway in PBMC specimens
To confirm in vitro findings above, we collect serums and PBMCs from representative asthma patients (n = 12) and controls (n = 11). Decreased percentage of methylation of ORMDL3 CpG island was observed in asthma patients compared with controls ( Fig. 7B and D) . ELISA results indicated the concentration of IL-6 and IL-8 was increased in asthma patients compared with controls ( Fig. 7E and F) . The protein level of MMP-9 and p-ERK were also increased in asthma patients compared with controls (Fig. 7C, G and H) . In addition, Pearson correlation test was used to determine whether the methylation status of ORMDL3 correlated with the production of IL-6 and IL-8 and the expression of p-ERK/MMP-9 pathway. The results indicated a strong negative correlation between methylation status of ORMDL3 and production of IL-6 and IL-8 or expression of p-ERK/MMP-9 pathway in clinical specimens (Fig. 7I-L ).
Discussion
Increased ORMDL3 transcriptional level had been found in the peripheral blood of recurrent wheeze patients and in bronchial epithelium in WT mice exposed to allergen challenge [10, 16] . ORMDL3 in peripheral-blood mononuclear cells (PBMCs) from adults stimulated by human rhinovirus was higher than unstimulated PBMCs [7] . In accordance with results reported by Caliskan M, et al. [7] , we demonstrated that ORMDL3 was significantly increased in the peripheral blood of childhood asthma patients compared to normal subjects.
Recently, human ORMDL3 overexpressing transgenic mice manifest spontaneous airway remodeling, increased fibrosis, mucus production, inflammation, and methacholine-induced hyperresponsiveness, which presented compelling evidence for ORMDL3 as a pathogenic factor [11] . Previous studies have suggested that ORMDL3 induced chemokine CXCL10 secretion regulated by the type I interferon (IFN) and endoplasmic reticulum (ER) stress [10] . In our studies, increased production of IL-6 and IL-8 was observed in NHBE and BEAS-2B cells after ORMDL3 overexpression. IL-6 and IL-8 have all been suggested to play a role in the development of asthma. Hence, that ORMDL3 increased the production of IL-6 and IL-8 presented new evidence for ORMDL3 as a pathogenic factor.
MMPs are proteolytic enzymes produced by epithelial and inflammatory cells and can induces infiltration of inflammatory cells through the basement membrane and extracellular matrix (ECM) by accelerating collagen and ECM deposition, which contribute to the progression of airway remodeling [20] . ERKs are essential for cell-cycle regulation, tissue development and the effect of growth factor. In a mouse model of asthma, inhibition of ERK1/2 blocks mucus production, airway inflammation and airway hyperreactivity [24] . Sustained expression of p-ERK1/2 was found in airway epithelium and smooth muscle biopsy samples from asthmatic patients. Furthermore, the expression level of p-ERK1/2 was associated with the clinical severity of asthma and eosinophilic infiltrates [25] . ROS-ERK-MMP-9 signaling pathway was reported to induce cell proliferation, migration and extracellular matrix collagen synthesis [26] . We found ORMDL3 overexpression induced production of IL-6 and IL-8 and expression of p-ERK/MMP-9 pathway. Hence, the activation of p-ERK/MMP-9 pathway may be associated with ORMDL3-induced production of IL-6 and IL-8, which provided novel evidence for the association between ORMDL3 expression and asthma. In clinical trials, IL-6 and IL-8 levels in uncontrolled asthmatics was significantly higher than that of the healthy controls [27] [28] [29] . In addition, MMP-9 and p-ERK were specifically elevated in asthmatic subjects compared with healthy controls [30] [31] [32] . In the present studies, the differential levels of IL-6, IL-8, MMP-9, and p-ERK in asthmatic patients and healthy controls were in accordance with the studies above.
Environmental epigenetic regulation has been increasingly recognized as an important studied area to explore the complex pathogenesis of childhood asthma [22] . We hypothesized DNA methylation influences ORMDL3 expression. To investigate the potential mechanism of ORMDL3 expression change, we treated NHBE and BEAS-2B cells with 5-Aza-CdR, which indicated that 5-Aza-CdR, as a global DNA demethylating reagent, increased ORMDL3 expression. Meanwhile, the percentage of methylation of ORMDL3 promoter was decreased in childhood asthma patients compared with controls. Therefore, DNA methylation may regulate the expression of ORMDL3. Epigenetic regulation included DNA methylation, histone modifications, chromatin remodeling, microRNAs. DNA methylation is one of the most well characterized epigenetic phenomena, which typically ensues at CpG islands in the promoter region of genes inhibiting gene expression [23, 33] . Recently, DNA methylation were reported to be associated with asthma and epigenetic changes might contribute to establish the asthma immune phenotype [34] . Two CpG cites (cg02305874 and cg16638648) located in the CpG island (CGI) of ORMDL3 were found significant differences in DNA methylation between asthmatics and controls. Meanwhile, cg02305874 and cg16638648 were also associated with ORMDL3 mRNA levels. Moreover, six CpG cites in the CpG island of ORMDL3 were less methylated in CD8 + T-cells compared with [15] . The modification of DNA methylation provides a link between the environment and gene expression. The results above indicated 5-AzaCdR increased ORMDL3 expression. Thus, we used BSP to measure the methylation status of the region in the promoter of ORMDL3. Compared with the control group, the percentage of ORMDL3 promoter region CpG island were significantly decreased after treated with 5-Aza-CdR. Then, we construct a plasmid named as pGL-261/+133 containing the CpG island. 5-Aza-CdR induced a marked increase in promoter activity in NHBE and BEAS-2B cells compared with controls. Contrary to 5-AzaCdR, M.SssI, as a DNA hypermethylation reagent, decreased promoter activity of the CpG island. These findings suggest that ORMDL3 promoter activity was negatively associated with the methylation status of the CpG island. When pGL-261/+133 was cloned in vitro, its original potential methylation status cannot be maintained due to lack of Methyltransferases. However, significant decrease of the activities of pGL-261/+133 was still observed after NHBE and BEAS-2B cells treated with 5-Aza-CdR. We speculated that in addition to regulating the methylation status of ORMDL3, 5-Aza-CdR might influence the transcriptional factors, such as Gata1, SP1 and CREB1, and then the transcriptional factors above bound to pGL-261/+133 resulted in the change of luciferase activity. Gata1, SP1 and CREB1 three transcriptional factors were predicted by JASPAR web site according to pGL-261/+133 sequence. In summary, DNA methylation was involved in the regulation of ORMDL3 expression. The occurrence of many diseases is related to changes of transcription initiation induced by alterations in DNA methylation. DNA methylation may be applied to make early prediction and prognosis evaluations for the occurrence and development of asthma [35] . CpG island, as an early event of disease, is more common than the whole-genome methylation. Thus, the methylation status of the CpG island in the promoter of ORMDL3 is promising for the prediction of asthma.
Huili Li et al. performed integrative expression and methylation analysis of 63 cancer cell lines (breast, colorectal, and ovarian) after treatment with 5-Aza-CdR. Gene Set Enrichment Analysis (GSEA) demonstrated interferon signaling, antigen presentation, chemokine and cytokine signaling were enrich in all three cancers. GSEA analyses of 5-Aza-CdR inducible genes identified 80 upregulated gene sets, including IL-6 and IL-8 [36] . In the present study, production of IL-6 and IL-8 were also increased in NHBE cells after treated with 5-Aza-CdR, which in agreement with the sequencing results from Huili Li et al. reported. Furthermore, our results indicated that 5-Aza-CdR-mediated cytokines upregulation was dependent on increased ORMDL3 expression. Increased ORMDL3 expression in airway epithelium stimulated by allergens lead to increased expression of asthma-associated cytokines, metalloproteases and the unfolded protein response (UPR). ORMDL3 regulates a number of pathways of potential importance to the pathogenesis of asthma, suggesting that ORMDL3 in airway epithelium may be a novel therapeutic target in asthma. WT mice inhalation allergen challenge (OVA or Alternaria) increased ORMDL3 expression [10] . In addition, single nucleotide polymorphism (SNP) linking chromosome 17q21 to asthma is also associated with increased ORMDL3 levels [8] . In our studies, we found the methylation status of CpG island of ORMDL3 promoter region could regulate ORMDL3 expression, which enriched the regulation mechanisms of ORMDL3 and the CpG island may be a novel therapeutic target in asthma.
In conclusion, we confirmed a negative correlation between methylation status of ORMDL3 and production of IL-6 and IL-8 or expression of p-ERK/MMP-9 pathway in vitro and in vivo. Demethylation of the CpG island in ORMDL3 promoter region may increase ORMDL3 expression and then induced IL-6 and IL-8 release in vitro. These findings enrich the understanding of ORMDL3 in the pathogenesis of asthma and more comprehensive studies remain to be elucidated in the future.
